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Abstract
Background
Persons with unsuppressed HIV viral load (VL) who disengage from care may experience
poor clinical outcomes and potentially transmit HIV. We assessed the feasibility and yield of
using the San Francisco Department of Public Health (SFDPH) enhanced HIV surveillance
system (eHARS) to identify and re-engage such persons in care.
Methods
Using SFDPH eHARS data as of 4/20/2012 (index date), we selected HIV-infected adults
who were alive, had no reported VL or CD4 cell count results in the past nine months (proxy
for “out-of-care”) and a VL>200 copies/mL drawn nine to 15 months earlier. We prioritized
cases residing locally for investigation, and used information from eHARS and medical and
public health databases to contact them for interview and referral to the SFDPH linkage ser-
vices (LINCS). Twelve months later, we matched-back to eHARS data to assess how HIV
laboratory reporting delays affected original eligibility, and if persons had any HIV laboratory
results performed and reported within 12 months after index date (‘new labs’).
Results
Among 434 eligible persons, 282 were prioritized for investigation, of whom 75 (27%) were
interviewed, 79 (28%) could not be located, and 48 (17%) were located out of the area.
Among the interviewed, 54 (72%) persons accepted referral to LINCS. Upon match-back to
eHARS data, 324 (75%) in total were confirmed as eligible, including 221 (78%) of the in-
vestigated; most had new labs.
Conclusions
Among the investigated persons presumed out-of-care, we interviewed and offered LINCS
referral to about one-quarter, demonstrating the feasibility but limited yield of our project.
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Matching to updated surveillance data revealed that a substantial minority did not disen-
gage from care and that most re-engaged in HIV care. Verifying persons’ HIV care status
with medical providers and improving timeliness of transfer and cross-jurisdictional sharing
of HIV laboratory data may aid future efforts.
Introduction
The benefits of combination antiretroviral therapy (ART), both for preserving the health of in-
fected persons and for preventing further HIV transmission, have been well established [1–3]
and support high-impact combination prevention strategies [4–7] to reduce the burden of
HIV/AIDS in the United States (US). As such, the Department of Health and Human Services
released revised recommendations in 2012 that all HIV-infected persons initiate ART regard-
less of immunologic status [8]. Realizing individual- and population-level benefits of ART de-
pends on timely diagnosis of HIV infection followed by linkage to and continuous engagement
in care.
National analyses of the continuum of HIV care indicate that substantial proportions of
HIV-infected persons are either unaware of their infection or, if aware, fail to stay engaged in
care. Nationally, only about 40% of persons living with HIV are consistently engaged in HIV
care [9–12], and only 19% to 25% are virally suppressed [9,13]. The percentages of virally sup-
pressed persons in the State of California and among persons living with HIV in San Francisco
are estimated to be higher [14,15]. Engagement in continuous HIV care facilitates achieving a
suppressed viral load; however, a recent study demonstrated that linkage to a single care visit
was not associated with viral suppression [16]. Persons disengaged from HIV care may have
unsuppressed viral loads, and could transmit HIV to their sexual and needle-sharing partners
[5,17,18]. Therefore, ensuring consistent engagement in HIV care is an important component
of comprehensive HIV prevention and disease control activities [19].
The Centers for Disease Control and Prevention (CDC) and local health departments have
been using routinely collected HIV surveillance data to monitor progress toward achieving the
goals of the National HIV/AIDS Strategy (NHAS) as well other indicators along the continuum
of care [11,16,20–23]. For example, in San Francisco, an estimated 50% of newly HIV diag-
nosed persons achieve viral suppression within 12 months of diagnosis [22], and 80% of all
HIV-infected persons are receiving consistent HIV care defined by biannual visits reported to
the HIV surveillance program [24].
In addition to monitoring NHAS progress, there is a growing interest in using existing HIV
surveillance and other healthcare databases for public health practice and interventions [25,26].
Increasingly, local health departments have been using surveillance data to inform program ac-
tivities to help link or re-link persons to HIV care [16,26–31]. We report here the findings from
our pilot project, the Re-engaging Surveillance-identified Viremic Persons (RSVP) project, which
used surveillance data to identify, contact, and re-engage in care HIV-infected persons with
unsuppressed HIV viral load who appeared to have disengaged from care in San Francisco.
Methods
Overview of the RSVP project
The RSVP project was launched on April 20, 2012 and implemented over the course of a 12-
month period by the San Francisco Department of Public Health (SFDPH). Our goals were to:
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(a) assess the feasibility of using the enhanced HIV/AIDS reporting system (eHARS) to identify
persons with unsuppressed plasma HIV RNA viral load (VL) who appeared to have fallen out
of HIV care, as evidenced by a gap in HIV VL and CD4 cell count laboratory reports in
eHARS; (b) assess the feasibility and utility of using information available in eHARS and addi-
tional databases (described below) to contact persons for re-linkage to HIV care; and (c) deter-
mine the degree to which contacted persons would engage the services of the SFDPH-
sponsored Linkage Integration Comprehensive Services (LINCS) Program for re-linkage to
HIV care or assistance with referrals to ancillary services [32]. Eligible persons who were locat-
ed and contacted by SFDPH staff and agreed to participate in this project met with SFDPH
staff at the health department or another convenient location, provided a written informed
consent, and completed a 30-minute interviewer-administered baseline survey. Participants re-
ceived $40 for their time, were offered services of the LINCS, and were invited to participate in
a follow-up interview three months later.
HIV surveillance-related information
California State law requires laboratories to report results from all confirmed HIV-positive an-
tibody tests, CD4 cell counts, and HIV VLs to local health departments with the patient’s
name, date of birth, gender, and name and address of the ordering medical provider [33]. Local
laboratory reports are entered by the SFDPH staff into eHARS, which is centrally maintained
for California by the California Department of Health, Office of AIDS (OA) [33]. The SFDPH
has access to information for all HIV cases diagnosed, treated, and reported in San Francisco,
including access to laboratory tests performed both inside and outside of San Francisco County
and entered into the California eHARS [15]. Laboratory data reported within San Francisco
County are>90% complete, accurate, and timely per CDC standards [34]. However, these
metrics may be lower in some other California counties. Vital status of HIV-infected Califor-
nians is verified by monthly matches with local and California vital statistics departments, and
yearly with the National Death Index and the Social Security Death Master File. Information
on place of residence for HIV-infected persons in San Francisco is collected at initial HIV diag-
nosis, and is updated every 18–24 months through medical record review, and when available,
through incoming laboratory reports. SFDPH surveillance staff have confidential access to elec-
tronic medical records of reported HIV cases at the county public hospital, public health clin-
ics, and many private medical facilities.
Population of interest, eligibility criteria, and project flow
Step 1: RSVP project eligibility. We selected as RSVP project-eligible all persons with
HIV infection reported to San Francisco eHARS as of April 20, 2012 (“index date”) who met
the following inclusion criteria: (a) aged 18 years and older and alive on the index date; (b) had
no HIV VL test result or CD4 cell count reported for nine months before the index date; and
(c) had an HIV VL > 200 copies/mL at last measurement obtained nine to 15 months earlier
(i.e., before the gap in laboratory reports) that is between January 20, 2011 and July 20, 2011
(“qualifying VL”) (Fig. 1). The second and third criteria in combination were used to identify
persons who had been in HIV care in the past but appeared to have had a relatively recent but
substantial gap in care of at least nine months. These criteria were selected to increase the odds
that these viremic persons had actually disengaged from HIV care and that they were still resid-
ing in the San Francisco area and could be found. At the time of this project, the Department
of Health and Human Services (DHHS) recommended that HIV-infected persons receive HIV
laboratory monitoring at least every six months and more frequently (every three months or
more often) if viremic or if recently started ART [8,35].
Re-Linking to HIV Care in San Francisco
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Step 2: Selecting persons for public health investigation. We limited our investigation to
persons living within San Francisco due to limited SFDPH staffing resources, and because
LINCS serviced only persons living locally. To this end, we determined the residence of cases
using information on the last known address in eHARS, and the location of the medical provid-
er who drew the qualifying HIV VL. We then investigated and sought to interview those per-
sons who: (a) resided in the Greater San Francisco Bay Area (GBA) defined as San Francisco,
Alameda, Contra Costa, San Mateo, Marin, Solano, Napa, Sonoma, Santa Clara, and Santa
Cruz counties; (b) had their last HIV VL or CD4 cell count test within the GBA; (c) were able
to speak English; and (d) were not incarcerated when contacted for an interview.
Step 3. Tracing, contacting, and screening of investigated persons. We reviewed avail-
able address information in eHARS (current address, and address at HIV/AIDS diagnosis) for
each person selected for public health investigation (also referred to as the “investigated” case).
We mailed a letter to the medical provider who ordered the qualifying HIV VL to inform him
or her about the RSVP project [36]. Providers could request that their patient not be contacted
for any reason, such as relocation away from San Francisco, complicating medical condition,
or potential for the project to interfere in the patient-provider relationship.
During the one-year project implementation period, we optimized the methods used to ob-
tain viable contact information. For the majority of investigated cases, we relied on contact in-
formation from eHARS or from patients’ electronic medical records maintained by their
providers. For persons who required enhanced efforts to be located, we used the SFDPH
Fig 1. Re-engaging Surveillance-Identified Viremic Persons (RSVP) Project in San Francisco, 2012–2013: Design and Timeline.
doi:10.1371/journal.pone.0118923.g001
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sexually transmitted disease report database, the California State databases of support services
in San Francisco (shelter and substance abuse), a person location service (Lexis/Nexis), and re-
reviewed medical records in search of any newly added contact information.
First, we contacted cases by calling each working telephone number up to 10 times; if tele-
phone contact was unsuccessful, a letter was sent inviting the person to contact the SFDPH
regarding a “health survey.” A dedicated confidential RSVP project telephone line was estab-
lished for potentially eligible cases to return calls. Upon telephone contact, we confirmed the
person’s identity by self-reported date of birth (or month and year) then scheduled the baseline
interview, which explored demographics, HIV care patterns, and reasons for being out of HIV
care (survey findings to be presented separately).
Project evaluation and data analyses
For all eligible cases, we “matched back” records to the San Francisco eHARS data available 12
months after the index date, to determine: (1) if any originally eligible persons were misclassi-
fied as “out of care” or viremic based on incomplete lab data at the time of index date; and (2)
if any eligible persons re-linked to HIV care within 12 months after the index date as evidenced
by new HIV VL or CD4 cell count results in eHARS.
Data security and confidentiality procedures
All data and analyses for this project were handled in accordance with the security and confi-
dentiality procedures used at the SFDPH for HIV/AIDS surveillance, as required by the State
of California Office of AIDS, California state law, and the CDC [36]. Participants were assigned
a unique RSVP project identification code used on interview forms, which were kept separate
from all personal identifying information. All personal identifying information, including an
encrypted electronic file linking a person’s name to RSVP project code, was stored in the secure
SFDPH HIV/AIDS surveillance case registry area. No data with personally identifiable infor-
mation were transferred to the CDC.
Ethics Statement
The project was determined by the CDC to be a public health practice related to epidemic or
endemic disease control activity, rather than human subject research, and was exempt from re-
view by a CDC institutional review board [37]. A HIPAA waiver was not obtained from project
participants as HIV surveillance data collected by health departments are HIPAA-exempt [38].
All project participants signed a written informed consent form.
Results
Population of interest
Out of 22,395 HIV-infected persons reported in the San Francisco eHARS presumed alive as of
April 20, 2012, and residing inside and outside the jurisdiction at the time of their diagnosis,
434 (1.9%) were eligible for the RSVP project (Fig. 1, Table 1). The qualifying HIV VL tests or-
dered by a city and county public hospital (n = 80, or 18%), private hospital (n = 65, or 15%),
private physician (n = 63, or 15%), public health clinic (n = 55, or 13%), Veterans Administra-
tion hospital (n = 6, or 1%), and the county jail (n = 5, or 1%). The ordering provider or venue
was unknown for 160 (37%) of laboratory reports.
Based on review of address and available provider information in eHARS, 152 (35%) of 434
RSVP project-eligible persons were excluded from further investigation: 113 living outside of
GBA, and 39 who had their qualifying HIV VL test ordered by a provider outside of GBA
Re-Linking to HIV Care in San Francisco
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Table 1. Characteristics* of the eligible population and investigated cases, the RSVP project, San Francisco, 2012–2013.
RSVP Project Eligible
(N = 434)
Investigated (N =
282)
Investigated, Interviewed
(N = 75)
Investigated, Not Interviewed†
(N = 207)
p-
value‡
Age, median years (IQR) 45 (37–51) 44 (36–50) 45 (37–50) 44 (35–51) 0.58
Sex, n (%)
Male 392 (90) 250 (89) 65 (87) 185 (89)
0.53
Female 42 (10) 32 (11) 10 (13) 22 (11)
HIV infection risk, n (%)
Man who has sex with men 366 (84) 228 (81) 64 (85) 164 (79)
0.74
Heterosexual 27 (6) 27 (10) 5 (7) 22 (11)
Injection drug user 27 (6) 16 (6) 4 (5) 12 (6)
Other or unknown 14 (3) 11 (4) 2 (3) 9 (4)
Race/ethnicity, n (%)
Non-Hispanic white 229 (53) 129 (46) 32 (43) 97 (47)
0.39
Non-Hispanic black 86 (20) 65 (23) 20 (27) 45 (22)
Non-Hispanic Asian/Pacific
Islander
22 (5) 20 (7) 2 (3) 18 (9)
Hispanic 82 (19) 63 (22) 20 (27) 43 (21)
Other 13 (3) 4 (1) 1 (1) 3 (1)
Unknown 2 (0) 1 (0) 0 (0) 1 (0)
Year of HIV diagnosis, n (%)
 1994 85 (20) 42 (15) 14 (19) 28 (14)
0.531995–2000 89 (21) 47 (17) 11 (15) 36 (17)
 2001 260 (60) 193 (68) 50 (67) 143 (69)
County of residence, n (%)
San Francisco (SF) 260 (60) 211 (75) 59 (79) 152 (73) 0.11
Greater Bay Area other than
SF
71 (16) 62 (22) 15 (20) 47 (23)
Other California county 61 (14) 1 (0) 1 (1) 0 (0)
Other State 33 (8) 0 (0) 0 (0) 0 (0)
Missing 9 (2) 8 (3) 0 (0) 8 (4)
Qualifying§ viral load, n (%)
> 200–999 copies/mL 70 (16) 34 (12) 11 (15) 23 (11)
0.20
1,000–9,999 copies/mL 129 (30) 93 (33) 27 (36) 66 (32)
10,000–100,000 copies/mL 164 (38) 112 (40) 31 (41) 81 (39)
> 100,000 copies/mL 71 (16) 43 (15) 6 (8) 37 (18)
CD4 count ǁ, n (%)
< 200 cells/mm3 112 (26) 70 (25) 13 (17) 57 (28)
0.09
200–349 cells/mm3 77 (18) 51 (18) 21 (28) 30 (14)
350–499 cells/mm3 68 (16) 44 (16) 11 (15) 33 (16)
500+ cells/mm3 138 (32) 97 (34) 26 (35) 71 (34)
Missing 39 (9) 20 (7) 4 (5) 16 (8)
Any ARV use, n (%)
Yes 246 (57) 145 (51) 39 (52) 106 (51)
1.00
No 188 (43) 137 (49) 36 (48) 101 (49)
* Based on eHARS data as of index date, 04/20/2012, unless otherwise specified.
† The 207 persons who were investigated but ultimately not interviewed included 59 (29%) who were found to be either ineligible during investigation
(non-English speakers), deceased, or residing outside of the Greater Bay Area.
‡ p-values comparing the 75 persons interviewed and 207 not interviewed were calculated usingWilcoxon-Mann-Whitney test or Fisher’s exact test.
§ Qualifying HIV viral load: last measurement from January 20, 2011 to July 20, 2011 time period.
ǁ Closest CD4 cell count result obtained between six months prior and three months after the qualifying viral load collection date.
Abbreviations: ARV; antiviral; IQR; interquartile range.
doi:10.1371/journal.pone.0118923.t001
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(Fig. 2). The remaining 282 cases selected for investigation were similar to the 434 persons eli-
gible for the RSVP project with respect to most socio-demographic and clinical variables
(Table 1). A similar distribution of provider types ordering the qualifying HIV VL (data not
shown) was also observed, with the exception that fewer (16%) had an unknown source. Only
three providers responded to SFDPH’s informational letter and asked to review the list of pa-
tients identified for RSVP project from their clinic site; none recommended that SFDPH re-
move any patients from consideration for RSVP project.
Results for RSVP project-investigated persons
Of the 282 persons whom we investigated and attempted to contact, 79 (28%) could not be lo-
cated, 48 (17%) had moved outside the GBA, and 30 (11%) did not respond to repeated at-
tempts to contact them (Fig. 2). Forty-four individuals (16%) were successfully contacted but
Fig 2. RSVP Project Implementation Flowchart.
doi:10.1371/journal.pone.0118923.g002
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not interviewed (30 refused to participate in the project, four were unable to speak English, and
10 agreed to be interviewed but did not subsequently show up to be interviewed). Six persons
(2%) were found to be deceased. The remaining 75 individuals (27%) completed the baseline
interview. The relative fractions of persons who were investigated and reached, located but not
reached, and not located are displayed in Fig. 3.
We sought updated contact information beyond what was available as of the index date in
eHARS or in the patient’s electronic medical record maintained by their provider for over half
(n = 161) of the 282 patients we investigated; 107 patients required further enhanced database
search efforts by SFDPH staff to be contacted or located.
Among the 75 persons interviewed, 87% were male, 85% gay, bisexual or other men who
had sex with men (MSM), 43% non-Hispanic white, and 79% had San Francisco as their coun-
ty of last residence in eHARS. Their characteristics were not statistically significantly different
from the 207 persons who were also investigated but could not be interviewed (Table 1).
eHARSmatch back: confirmation of eligibility at index date
Upon match back to eHARS 12 months after the index date, 110 (25%) of the 434 persons eligi-
ble for RSVP project had additional laboratory results available in eHARS that were not present
at the index date. Therefore, these persons were either in HIV care or were not viremic at last
VL measurement pre-index date and, in retrospect, were not RSVP project-eligible. Of these
110 persons, 107 had HIV VL or CD4 cell count result(s) performed during the nine months
before index date but entered into eHARS in the 12 months after the index date and three per-
sons had last HIV VL< 200 copies/mL. Notably, 61 (22%) of the 282 investigated cases and 25
(33%) of the 75 interviewed persons had laboratory data available after the index date and
were, in retrospect, not RSVP project-eligible (Table 2).
eHARSmatch back: re-engagement in HIV care during the 12 months
after index date
Among the 434 persons eligible for participation in the RSVP project, 249 (57%) had at least
one new HIV VL or CD4 cell count performed and reported to eHARS during 12 months after
Fig 3. Disposition for 282 Investigated Cases, the RSVP Project, San Francisco, 2012–2013 (n = 282).
doi:10.1371/journal.pone.0118923.g003
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index date and 104 (24%) had two or more laboratory tests at least 90 days apart during this
12-month period (Table 2). These percentages, suggestive of re-engagement in HIV care, were
somewhat higher for the persons who were investigated and interviewed (Table 2). After ex-
cluding the 110 persons who, in retrospect, due to delayed reporting of HIV VL and CD4 cell
count data did not meet the original eligibility criteria, the percentages with one or more labo-
ratory test result among the remaining 324 confirmed eligible persons were similar to those re-
ported for 434 persons and similar comparing the relevant subsets (i.e., total, investigated, and
interviewed).
With respect to the timing of the new HIV laboratory measurements, among 75 persons in-
terviewed, 13 (17%) did not have any laboratory test(s) reported after index date, 54 (72%) had
a laboratory test after the index date and before their RSVP project visit, and eight (11%) had a
laboratory test only after their RSVP project visit.
Use of LINCS services by interviewed persons
Of the 75 interviewed persons, 54 (72%) accepted a referral to LINCS. LINCS staff determined
that 29 (54%) of these persons had truly fallen out of HIV care and therefore attempted to con-
tact these persons to offer re-engagement in care support. To date, 19 (66%) persons have been
successfully contacted by LINCS staff and 15 linked to care, of whom 12 have been documented
as having attended a new primary HIV care appointment; three who were living outside of San
Francisco and one who became incarcerated after his interview. The remaining 25 persons
were determined by LINCS staff to be engaged in HIV care per self-report or from information
available in the SFDPH’s clinical record database and were offered referrals to ancillary services
(e.g., social services, mental health care).
Discussion
The RSVP project focused on a high-priority HIV-infected population: persons who were out-
of-care and viremic, and thus, at increased risk for poor clinical outcomes and potentially
transmitting HIV to others. Nonetheless, having previously received HIV care, these persons
Table 2. Match-back to eHARS data available 12 months after index date to confirm persons’ original eligibility and to assess re-engagement in
care based on new HIV laboratory data, the RSVP Project, San Francisco, 2012–2013.
RSVP Project-eligible Investigated Interviewed
Eligible persons N = 434 N = 282 N = 75
Confirm eligibility at index date
Not eligible* 110 (25%) 61 (22%) 25 (33%)
Confirmed eligible N = 324 N = 221 N = 50
Assess re-linkage to care within 12 months after index date
Among eligible persons
 1 VL or CD4 cell count 249 (57%) 181 (64%) 62 (83%)
 2 labs (VL or CD4 cell count)  90 days apart 104 (24%) 80 (28%) 35 (47%)
Among confirmed-eligible
 1 VL or CD4 cell count 171 (53%) 134 (61%) 41 (82%)
 2 labs (VL or CD4 cell count)  90 days apart 73 (23%) 60 (27%) 24 (48%)
NOTE: VL, viral load; index date was April 20, 2012.
* Subset of persons originally thought to be eligible for the RSVP project who, in retrospect, were not eligible based on additional laboratory results
performed before index date but only reported to eHARS during the 12 months after the index date.
doi:10.1371/journal.pone.0118923.t002
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were possibly more willing to re-link to treatment services if provided additional support
[39,40]. Starting with routinely collected eHARS data in San Francisco, we were able to identify
and investigate these persons who appeared to be out of HIV care for at least nine months, gen-
erate dispositions for all of them, but ultimately reached and interviewed only a small subset:
75 (27%) of 282 persons investigated. Many persons who we believed resided locally had
moved outside the GBA, or could not be located or reached. In retrospect, based on updated
laboratory data reported to eHARS, approximately 25% of all persons originally identified as
eligible for the RSVP project were actually not eligible (i.e., had evidence of recent HIV care).
Despite the project’s modest yield, the majority of interviewed persons accepted referral to the
LINCS program, and some benefited from LINCS services with re-engaging to HIV care.
Our approach bore some similarities to HIV linkage and re-engagement programs reported
by other health departments [16,27–30], and yielded several lessons that may guide further re-
linkage-to-care activities in San Francisco and elsewhere. The RSVP project was resource-in-
tensive in staff time required to obtain current contact information and find eligible persons.
The HIV surveillance registry did not contain sufficient information to locate persons; phone
numbers were not (and continue not to be) collected, and until recently, the latest address in-
formation collected was not associated with a date, and thus, potentially outdated to an un-
known extent. This necessitated searches for phone numbers and address information in
medical records from the clinical provider who ordered the last HIV VL. When such contact
information was unavailable or unproductive, we used additional databases to find locating in-
formation, including other disease registries and a commercial person-search database. We
also found that a substantial minority of persons we attempted to locate were homeless or tran-
sitionally housed, transient, and frequently had non-working phone numbers, making reaching
them by phone or conventional postal service challenging. Notably, through our eHARS
match-back procedure one year later, we found that over half of persons eligible for RSVP proj-
ect participation had at least one new HIV VL or CD4 cell count reported to eHARS during the
12-month period after the index date in April 2012, suggesting that these persons had re-en-
gaged in HIV care or were never truly out of care but just had sporadic HIV laboratory mea-
surements performed either within or outside the jurisdiction [12,15,41].
The success rates of our and others’ re-linkage programs likely varied due to: (i) differences
in definitions of the eligible population, particularly whether or not local residence was re-
quired [27] and duration of time since last documented HIV laboratory measurement [30]; (ii)
completeness and timeliness of HIV laboratory and address information in local surveillance
registries and other databases [16]; (iii) degree of collaboration and information exchange be-
tween the Department of Health and medical providers for identifying and tracing people who
may have fallen out of HIV care [42]; and (iv) actual rates of retention in HIV care, geography,
mobility, and HIV care-seeking patterns of persons in different localities [20–22,41].
Our project was subject to several limitations. Laboratory results in the San Francisco sur-
veillance registry are reported with some delay for a fraction of persons, particularly if they
have received testing in counties outside of San Francisco; these counties transfer results to the
California Department of Health for processing before making them available to the SFDPH.
Although we allowed for a nine-month period without laboratory measurements as an eligibili-
ty criterion in our project, laboratory reporting delays still impaired our ability to accurately
identify eligible persons. The yield of our project was also lowered by searching for persons
who, rather than being out of HIV care, were instead undergoing HIV laboratory testing either
less frequently within the GBA, or outside the GBA. Although we attempted to exclude all per-
sons who appeared to have moved out of the GBA from investigation, not all could be excluded
a priori due to outdated information in the surveillance registry regarding their residential ad-
dress or missing information about the HIV provider who drew the qualifying VL. In the
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course of our investigation, we found that a substantial fraction of persons had moved out of
the GBA, as was the case for a similar health department project in the Seattle area [31]. Our in-
vestigative and outreach efforts were multipronged and concurrent and we were unable to sys-
tematically assess the source of information which led to a successful patient contact, including
his/her returning a call to the RSVP project staff.
Furthermore, we did not seek and cannot determine the extent to which re-engagement was
attributable to contact with RSVP project staff or support provided by LINCS. All eligible per-
sons, whether interviewed or not, received at least one phone call inviting them to enroll in a
Health Department project, which may have affected their care-seeking behavior. Also, persons
who were interviewed may have been more motivated to resume HIV care than those who
were not interviewed. Individuals who were interviewed and engaged with LINCS may have
had greater unmet needs than those who were interviewed but did not engage with LINCS.
The RSVP project was essentially a pilot project, had no dedicated budget, and was con-
ducted with no additional staffing except for a part-time CDC assignee who assisted in its de-
sign and launch. We did not systematically track and document how resource intensive this
project was. As in other studies and pilot projects of this type [29,30,39,43,44], the RSVP proj-
ect benefitted from leveraging HIV surveillance and LINCS program staff resources to offer a
difficult to reach population services they needed rather than just an interview about reasons
for disengaging from HIV care. Nonetheless, we relied on existing SFDPH surveillance and
public health investigator staff and our success in locating and interviewing eligible persons
was likely less than what it would have been had additional dedicated staffing and funding re-
sources been available.
This pilot project provided important information to the health department about the logis-
tics, utility, and yield of using HIV surveillance data to identify and trace persons who appeared
to have disengaged from HIV care. In summary, examining routinely reported HIV laboratory
reports in an HIV/AIDS surveillance registry was a feasible, albeit imperfect, method to identify
persons presumed lost to HIV care. In selecting eligible persons from the surveillance registry,
we had to contend with incomplete or outdated HIV case contact information, and the fre-
quent absence of adequately detailed information regarding medical providers who ordered
the last HIV VL test. As health departments continue to develop enhanced electronic laborato-
ry reporting for all HIV-related test results collected in the course of care after HIV diagnosis,
the utility of HIV surveillance data to investigate, contact, and re-engage persons in care will
continue to improve. Based on our RSVP project experience, we recommend that future proj-
ects build upon partnerships of health departments and medical providers, and utilize upfront
information from both HIV surveillance and medical records to better focus on persons who,
based on available information from all sources, still live in the jurisdiction and are not receiv-
ing care elsewhere. Strengthening the framework [26,36] for sharing securely and in a timely
fashion surveillance data between counties and states may improve local health departments’
success in routinely using HIV surveillance data to identify and re-engage people in HIV care.
Acknowledgments
We thank the participants who volunteered for this project, and staff who contributed to design
and execution of this project. We would like to especially acknowledge Willi McFarland, John
T. Brooks, and Grant Colfax for their input on the project design; Ling Hsu, Tony Su, and Pris-
cilla Chu for data management assistance; Stephanie Cohen, Noah Carraher, Andrew Rey-
nolds, Jennifer Vanaman, Nyisha Underwood, Sally Stephens, and Kyle Bernstein for their
work with the Linkage, Integration, and Comprehensive Services (LINCS) program; and
Re-Linking to HIV Care in San Francisco
PLOS ONE | DOI:10.1371/journal.pone.0118923 March 6, 2015 11 / 14
Rolando Ramirez, Zenelia Roman, Tara Gonzalez, Kristina Dhillon, and Tony Buckman for
their help contacting and interviewing participants.
Author Contributions
Conceived and designed the experiments: KB SS. Performed the experiments: KB SS MPMJC
MYC EA VD NM. Analyzed the data: MJC KB SS. Contributed reagents/materials/analysis
tools: MJC MYC EA. Wrote the paper: KB SS MJC MPMYC EA VD NM. The manuscript was
critically reviewed and subsequently approved by: KB MJC MPMYC EA VD NM SS.
References
1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasany N, et al. (2011) Preven-
tion of HIV-1 infection with early antiretroviral therapy. New England Journal of Medicine 365: 493–
505. doi: 10.1056/NEJMoa1105243 PMID: 21767103
2. Donnell D, Baeten JM, Kiarie J, Thomas KK, StevensW, Cohen CR, et al. (2010) Heterosexual HIV-1
transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 375: 2092–
2098. doi: 10.1016/S0140-6736(10)60705-2 PMID: 20537376
3. Department of Health and Human Services (2013) HIV/AIDS Bureau (HAB) HIV performance mea-
sures. Available: http://hab.hrsa.gov/deliverhivaidscare/habperformmeasures.html Accessed 20 No-
vember 2014.
4. El-Sadr WM, Affrunti M, Gamble T, Zerbe A (2010) Antiretroviral therapy: a promising HIV prevention
strategy? J Acquir Immune Defic Syndr 55 Suppl 2: S116–S121. doi: 10.1097/QAI.0b013e3181fbca6e
PMID: 21406980
5. Centers for Disease Control and Prevention (2011) Vital signs: HIV prevention through care and treat-
ment—United States. MMWR 60: 1618–1623. PMID: 22129997
6. Department of Health and Human Services (2011) High-impact HIV prevention: CDC’s approach to re-
ducing HIV infections in the United States. Available: http://www.cdc.gov/hiv/policies/hip.html Ac-
cessed 20 November 2014.
7. Sorensen SW, Sansom SL, Brooks JT, Marks G, Begier EM, Buchacz K, et al. (2012) A mathematical
model of comprehensive test-and-treat services and HIV incidence among men who have sex with
men in the United States. Plos One DOI 10.1371/journal.pone.0029098.
8. Department of Health and Human Services (2013) Guidelines for the use of antiretroviral agents in HIV-
infected adults and adolescents. Published February 12, 2013. Available: http://aidsinfo.nih.gov/
guidelines Accessed 20 November 2014.
9. Gardner EM, McLees MP, Steiner JF, Del RC, BurmanWJ (2011) The spectrum of engagement in HIV
care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 52:
793–800. doi: 10.1093/cid/ciq243 PMID: 21367734
10. Marks G, Gardner LI, Craw J, Crepaz N (2010) Entry and retention in medical care among HIV-diag-
nosed persons: a meta-analysis. AIDS 24: 2665–2678. doi: 10.1097/QAD.0b013e32833f4b1b PMID:
20841990
11. Hall HI, Gray KM, Tang T, Li J, Shouse L, Mermin J (2012) Retention in care of adults and adolescents
living with HIV in 13 U.S. areas. J Acquir Immune Defic Syndr 60: 77–82. doi: 10.1097/QAI.
0b013e318249fe90 PMID: 22267016
12. Mugavero MJ, Amico KR, Horn T, Thompson MA (2013) The state of engagement in HIV care in the
United States: from cascade to continuum to control. Clin Infect Dis 57: 1164–1171. doi: 10.1093/cid/
cit420 PMID: 23797289
13. Hall HI, Frazier EL, Rhodes P, Holtgrave DR, Furlow-Parmley C, Tang T, et al. (2013) Differences in
Human Immunodeficiency Virus care and treatment among subpopulations in the United States. JAMA
Internal Medicine 173: 1337–1344. doi: 10.1001/jamainternmed.2013.6841 PMID: 23780395
14. California Department of Public Health, Office of AIDS (2013) Continuum of HIV care in California.
Available: http://www.cdph.ca.gov/programs/aids/Documents/HIVCareContinuum-Dec2013.pdf Ac-
cessed 20 November 2014.
15. San Francisco Department of Public Health (2012) The HIV/AIDS Epidemiology Annual Report 2012.
Available at: http://www.sfdph.org/dph/comupg/oprograms/HIVepiSec/default.asp Accessed 20 No-
vember 2014.
16. Dombrowski JC, Kent JB, Buskin SE, Stekler JD, Golden MR (2012) Population-based metrics for the
timing of HIV diagnosis, engagement in HIV care, and virologic suppression. AIDS 26: 77–86. doi: 10.
1097/QAD.0b013e32834dcee9 PMID: 22008656
Re-Linking to HIV Care in San Francisco
PLOS ONE | DOI:10.1371/journal.pone.0118923 March 6, 2015 12 / 14
17. Marks G, Crepaz N, Senterfitt JW, Janssen RS (2005) Meta-analysis of high-risk sexual behavior in
persons aware and unaware they are infected with HIV in the United States—Implications for HIV pre-
vention programs. J Acquir Immune Defic Syndr 39: 446–453. PMID: 16010168
18. Mugavero MJ, Amico KR, Westfall AO, Crane HM, Zinski A, Willig JH, et al. (2012) Early retention in
HIV care and viral load suppression: implications for a test and treat approach to HIV prevention. J
Acquir Immune Defic Syndr 59: 86–93. doi: 10.1097/QAI.0b013e318236f7d2 PMID: 21937921
19. Office of National AIDS Policy (2013) National HIV/AIDS strategy for the United States. Available:
http://www.whitehouse.gov/administration/eop/onap/nhas/ Accessed 20 November 2014.
20. Torian LV, Wiewel EW (2011) Continuity of HIV-related medical care, New York City, 2005–2009: Do
patients who initiate care stay in care? AIDS Patient Care STDs 25: 79–88. doi: 10.1089/apc.2010.
0151 PMID: 21284498
21. Hsu LC, Chen M, Kali J, Pipkin S, Scheer S, et al. (2011) Assessing receipt of medical care and dispari-
ty among persons with HIV/AIDS in San Francisco, 2006–2007. AIDS Care 23: 383–392. doi: 10.1080/
09540121.2010.507740 PMID: 21347902
22. MuthulingamD, Chin J, Hsu L, Scheer S, Schwarcz S (2013) Disparities in engagement in care and
viral suppression among persons with HIV. J Acquir Immune Defic Syndr 63: 112–119. doi: 10.1097/
QAI.0b013e3182894555 PMID: 23392459
23. Valdiserri RO, Forsyth AD, Yakovchenko V, Koh HK (2013) Measuring what matters: development of
standard HIV core indicators across the US Department of Health and Human Services. Public Health
Reports 128: 12–17. PMID: 24179274
24. Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, et al. (2009) Primary care
guidelines for the management of persons infected with Human Immunodeficiency Virus: 2009 update
by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 49:
651–681. doi: 10.1086/605292 PMID: 19640227
25. Fairchild AL, Bayer R (2011) HIV surveillance, public health, and clinical medicine—will the walls come
tumbling down? New England Journal of Medicine 365: 685–687. doi: 10.1056/NEJMp1107294 PMID:
21864165
26. Sweeney P, Gardner LI, Buchacz K, Garland PM, Mugavero MJ, Bosshart JT, et al. (2013) Shifting the
paradigm: using HIV surveillance data as a foundation for improving HIV care and preventing HIV infec-
tion. The Milbank Quarterly 91: 558–603. doi: 10.1111/milq.12018 PMID: 24028699
27. Udeagu CC, Webster-Leon T, Bocour A, Michel P, Shepard C (2012) Using surveillance data to identify
HIV-positive persons out-of-care (OOC) in New York City (NYC) and offer linkage to care and HIV part-
ner services. Journal of the American Medical Informatics Association 15: 146–146.
28. Project Inform (2012) Using surveillance and other data to improve HIV care linkage and retention.
Available: http://www.projectinform.org/pdf/surveillance_0313.pdf Accessed 20 November 2014.
29. Udeagu C-CN, Webster TR, Bocour A, Michel P, Shepard CW (2013) Lost or just not following up: pub-
lic health effort to re-engage HIV-infected persons lost to follow-up into HIV medical care. AIDS 27:
2271–2279. doi: 10.1097/QAD.0b013e328362fdde PMID: 23669157
30. Buskin SB, E, Bauer A, Kent J, Garcia-Smith H, Wood R (2011) HIV infected individuals presumed to
not be receiving HIV care: a surveillance program evaluation for investigations and referrals in Seattle,
WA. Journal of HIV/AIDS Surveillance and Epidemiology 3: Available: http://www.ieph.org/hase/jhase.
htm Accessed 20 November 2014.
31. Buskin SE, Kent JB, Dombrowski JC, Golden MR (2014) Migration distorts surveillance estimates of
engagement in care: results of public health investigations of persons who appear to be out of HIV care.
Sexually Transmitted Diseases 41: 35–40. doi: 10.1097/OLQ.0000000000000072 PMID: 24326579
32. San Francisco Department of Public Health (2014) Linkage, Integration, Navigation, and Comprehen-
sive Services (LINCS) Program. Available: http://www.sfhiv.org/our-services/linkage-integration-
navigation-and-comprehensive-services-lincs/ Accessed 20 November 2014.
33. California Department of Public Health, Office of AIDS (2011) HIV/AIDS case reporting. Available:
http://www.cdph.ca.gov/programs/aids/Pages/tOAHIVRptgSP.aspx Accessed 20 November 2014.
34. Hall HI, Mokotoff ED, Advisory G (2007) Setting standards and an evaluation framework for human
immunodeficiency virus/acquired immunodeficiency syndrome surveillance. Journal of Public Health
Management and Practice 13: 519–523. PMID: 17762698
35. Department of Health and Human Services (2008) Guidelines for the use of antiretroviral agents in HIV-
infected adults and adolescents. Published November 3, 2008. Available: http://aidsinfo.nih.gov/
guidelines Accessed 20 November 2014.
36. Centers for Disease Control and Prevention (2011) Data security and confidentiality guidelines for HIV,
Viral hepatitis, sexually transmitted disease, and tuberculosis programs: standards to facilitate sharing
Re-Linking to HIV Care in San Francisco
PLOS ONE | DOI:10.1371/journal.pone.0118923 March 6, 2015 13 / 14
and use of surveillance data for public health action. Available: http://www.cdc.gov/nchhstp/
programintegration/docs/PCSIDataSecurityGuidelines.pdf Accessed 20 November 2014.
37. Centers for Disease Control and Prevention (2010) Distinguishing public health research and public
health nonresearch policy. Available: http://www.cdc.gov/od/science/integrity/docs/cdc-policy-
distinguishing-public-health-research-nonresearch.pdf Accessed 20 November 2014.
38. Centers for Disease Control and Prevention (2003) HIPAA privacy rule and public health. Guidance
from the CDC and the Department of Health and Human Services MMWR 52: 12.
39. Higa DH, Marks G, Crepaz N, Liau A, Lyles CM (2012) Interventions to improve retention in HIV primary
care: a systematic review of U.S. studies. Current HIV/AIDS Reports 9: 313–325. doi: 10.1007/
s11904-012-0136-6 PMID: 22996171
40. Gardner LI, Marks G, Craw JA, Wilson TE, Drainoni M-L, Moore RD, et al. (2012) A low-effort, clinic-
wide intervention improves attendance for HIV primary care. Clin Infect Dis 55: 1124–1134. PMID:
22828593
41. Gardner EM, Daniloff E, Thurn MW, Reirden DH, Davidson AJ, Johnson SC, et al. (2013) Initial linkage
and subsequent retention in HIV care for newly diagnosed HIV-infected cohort in Denver, Colorado. J
Int Assoc Provid AIDS Care 12:384–90 doi: 10.1177/2325957413500532 PMID: 23962912
42. Magnus M, Herwehe J, Gruber D, Wilbright W, Shepard E, et al. (2012) Improved HIV-related outcomes
associated with implementation of a novel public health information exchange. International Journal of
Medical Informatics 81: E30–E38. doi: 10.1016/j.ijmedinf.2012.06.005 PMID: 22883431
43. Wohl AR, GarlandWH, Wu J, Au C-W, Boger A, Dierst-Davies R, et al. (2011) A youth-focused case
management intervention to engage and retain young gay men of color in HIV care. AIDS Care 23:
988–997. doi: 10.1080/09540121.2010.542125 PMID: 21390879
44. Hightow-Weidman LB, Jones K, Wohl AR, Futterman D, Outlaw A, Phillips G, et al. (2011) Early linkage
and retention in care: findings from the Outreach, Linkage, and Retention in Care Initiative among
young men of color who have sex with men. AIDS Patient Care and STDs 25: S31–S38. doi: 10.1089/
apc.2011.9878 PMID: 21711141
Re-Linking to HIV Care in San Francisco
PLOS ONE | DOI:10.1371/journal.pone.0118923 March 6, 2015 14 / 14
